Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Price vs Fair Value ; 1-Star Price: $1, ; 5-Star Price: $ ; Economic Moat: None ; Capital Allocation: —. Cytokinetics, Incorporated (CYTK) ; Apr 26, , , , , ; Apr 25, , , , , Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Cytokinetics Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · CYTK Overview · Key Data · Performance · Analyst Ratings. Sell; Under. CYTK Price · $ ; Market Cap · $B ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Cytokinetics to be priced at by the end of this quarter and at View Cytokinetics, Incorporated CYTK stock quote prices, financial information, real-time forecasts, and company news from CNN. Date Requested, Open Price, Day High, Day Low, Closing Price, Volume, Split Adjustment Factor. September 3, , $, $, $, $, 1,, Cytokinetics Incorporated (CYTK). $(%). Cytokinetics (CYTK) reported Q2 earnings per share (EPS) of -$, missing estimates of -$ by %. In the same quarter last year, Cytokinetics's. The current price of CYTK is USD — it has decreased by −% in the past 24 hours. Watch Cytokinetics, Incorporated stock price performance more closely. Oops, something went wrong. Check your browser's developer console for more details. Stock Information. Stock Quote · Stock Chart · Historical Price Lookup.
Cytokinetics, Incorporated (US:CYTK) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission . Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Cytokinetics Inc. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CYTK will report Key Data ; Exchange. NASDAQ-GS ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; Today's High/Low. $/$ ; Share Volume. , Research Cytokinetics' (Nasdaq:CYTK) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Cytokinetics Inc CYTK:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/08/24 · 52 Week Low Cytokinetics (CYTK) PT Raised to $92 at JefferiesJefferies analyst Akash Tewari raised the price target on Cytokinetics (NASDAQ: CYTK) to $ (from $). Cytokinetics (CYTK) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.
Cytokinetics, Incorporated (ostashkovadm.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated. 59 minutes ago. Cytokinetics, Incorporated (CYTK) Q3 Earnings Call Transcript. CYTK earnings call for the period ending September 30, Motley Fool Transcribers |. The 68 analysts offering price forecasts for Cytokinetics have a median target of , with a high estimate of and a low estimate of Quote Overview ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High:
CYTK, Cytokinetics, Incorporated, day gainers, stock prices dynamics, stock of the day